Upcoming conferences

Schedule a meeting with our drug development and manufacturing experts at AAPS & CPhI this November

AAPS & CPhI 2019

Quotient is exhibiting at both AAPS in San Antonio, TX and CPhI in Frankfurt this November!  Meet with our drug development and manufacturing experts at either conference to discuss your drug program's needs and learn how Quotient can help you quickly and cost effectively achieve your development milestones.
Click Here to Schedule a Meeting at AAPS Click Here to Schedule a Meeting at CPhI

AAPS PharmSci 360
Dates: November 4-6
Location: San Antonio, TX

Booth #627

CPhI Worldwide

Dates: November 5-7

Location: Frankfurt, Germany

Booth #121C52

Presentations at AAPS & CPhI



Join Quotient for a Lunch & Learn Seminar during AAPS entitled: Analysis from the Tufts Center for the Study of Drug Development to Assess the Financial Benefits from Translational Pharmaceutics®:  A Platform for Accelerating Product Development

Event Details:
When:Tuesday, November 5th
Time: 11:00am to 1:00pm
Location: Ruth Chris' Steakhouse - 600 E Market St, San Antonio, TX 78205

Click Here to Register


Quotient will also be delivering a Pharma Insight Briefing at CPhi Worldwide.

Join us for a 30 minute seminar in the ICSE Hall (location to be confirmed) @ 15:50 on Tuesday 5th October 

Seminar title - Analysis from the Tufts Center for the Study of Drug Development (CSDD) to Assess the Financial Benefits from Translational Pharmaceutics®: A Platform for Accelerating Product Development

Speaker - John McDermott, Executive Director and Head, Drug Development Solutions (EMEA) 

Quotient will also be presenting 5 posters at AAPS this year (Dates/Times/Locations listed below)

  • Development of a solubilized capsule formulation using co-micronisation and precipitation inhibition
    -Wednesday at 10:30am  |  Forum 04  |  Monitor 26
  • Comparison of two in-silico modeling programs, ADMET Predictor and Percepta to predict intrinsic solubility and pKa of poorly soluble drugs
    -Tuesday at 2:30pm  |  Forum 04  |  Monitor 25
  • A Phase I study allowing clinical screening of multiple solubility-enhancement formulation technologies, and an assessment of food, PPI and dose linearity assessment with the selected formulation of BOS172767, in healthy volunteers
    -Wednesday at 10:30am  |  Forum 04  |  Monitor 23
  • Applications and benefits of healthy volunteer trials to accelerate oncology drug development
    -Tuesday at 10:30am  |  Forum 13  |  Monitor 87
  • Rapid transition of a novel Celecoxib formulation from a fit-for-phase presentation to a commercializable product using an innovative integrated drug development and clinical testing platform.
    -Tuesday at 12:30pm  |  Forum 04  |  Monitor 28

If you would like a copy of one of our posters please feel free to email Kimberly Burrell by clicking here.

Ask us a question